Document Detail

Rationale and design for the SARIS trial; effect of statin on atherosclerosis and vascular remodeling assessed with intravascular sonography. Effect of Statin on Atherosclerosis and vascular Remodeling assessed with Intravascular Sonography.
MedLine Citation:
PMID:  11800418     Owner:  NLM     Status:  MEDLINE    
PURPOSE: The SARIS study (effect of Statin on Atherosclerosis and vascular Remodeling assessed with Intravascular Sonography) is a prospective randomized multicenter trial designed to assess both morphological and functional cardiovascular effects of atorvastatin.
METHODS: Participating centers will include 50 patients with normal to mildly elevated cholesterol levels eligible for balloon angioplasty and/or stent placement of the common iliac artery. Patients will be randomized to 1-year treatment with either low-dose (10 mg) or high-dose (80 mg) atorvastatin. The morphological effects of atorvastatin will be studied using intravascular ultrasound (IVUS); the effect of atorvastatin on both plaque volume and vascular remodeling seen at 1-year follow-up will be investigated. The functional cardiovascular effects of atorvastatin will be studied using dobutamine stress echocardiography (DSE); the effect of atorvastatin on myocardial coronary flow reserve at 6-months and 1-year follow-up will be investigated. The aims of the present study are noteworthy in respect that (1) IVUS is the only available technique to sensitively measure the effect of atorvastatin on both intimal hyperplasia and vascular remodeling, and (2) DSE is a non-invasive test to objectively quantify the effect of atorvastatin on the functionality of the coronary artery.
T Hagenaars; E J Gussenhoven; D Poldermans; H van Urk; A van der Lugt
Related Documents :
176718 - Serum beta-lipoprotein subfractions in polyacrylamide gel electrophoresis associated wi...
14965198 - Insights into early and rapid effects of statin therapy after coronary interventions.
9013268 - Lipoprotein analyses in patients with stable angina and acute coronary syndrome.
24014808 - Vagal modulation of cardiac ventricular arrhythmia.
14967718 - Impact of microvascular dysfunction on left ventricular remodeling and long-term clinic...
8786868 - Exercise 201tl/rest 99tcm-tetrofosmin myocardial perfusion imaging: a convenient protoc...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy     Volume:  15     ISSN:  0920-3206     ISO Abbreviation:  Cardiovasc Drugs Ther     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2002-01-21     Completed Date:  2002-05-14     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  8712220     Medline TA:  Cardiovasc Drugs Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  339-43     Citation Subset:  IM    
Department of Experimental Echocardiography, Erasmus Medical Center Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Anticholesteremic Agents / therapeutic use*
Arteriosclerosis / drug therapy*,  ultrasonography
Cholesterol / analysis
Coronary Circulation / drug effects*
Echocardiography, Stress / methods
Heptanoic Acids / therapeutic use*
Hyperplasia / drug therapy
Multicenter Studies as Topic
Prospective Studies
Pyrroles / therapeutic use*
Sensitivity and Specificity
Tunica Intima / drug effects*,  pathology
Reg. No./Substance:
0/Anticholesteremic Agents; 0/Heptanoic Acids; 0/Pyrroles; 57-88-5/Cholesterol; A0JWA85V8F/atorvastatin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The effect of verapamil on response of coronary vasomotion to handgrip exercise in symptomatic patie...
Next Document:  Estimation of optimum requirements for indoor air quality and energy consumption in some residences ...